The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.
about
Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvantAdvax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.Inulin isoforms differ by repeated additions of one crystal unit cell.A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protectionImmunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.Inulin crystal initiation via a glucose-fructose cross-link of adjacent polymer chains: atomic force microscopy and static molecular modelling.Physical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation.Carbohydrate-based vaccine adjuvants - discovery and development.Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant.Apoptosis of human tongue squamous cell carcinoma cell (CAL-27) induced by Lactobacillus sp. A-2 metabolites.Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant.
P2860
Q28384323-23831FC9-5F2B-40D0-915D-5DBC60F013DBQ30379559-BA23C031-CA92-43F8-BE08-5BD4A3EB1A84Q30389743-AB86C91F-B71B-47ED-9167-B2C545225976Q33718615-48EAB810-EADA-4CC4-A0E1-22FD632FFAEAQ33735067-8A06DE16-371E-4F22-B41F-1DFB9A18245CQ33940730-76A4C673-A5CC-4B24-BF6E-D9F060262046Q34621859-F275F41D-F19B-4D06-A823-58EB1478EC4FQ34719089-8F7B132B-4C58-4EBD-892C-7D429A71DEC0Q36805270-395EACB3-B476-484B-B27B-471C1133B8C6Q38587300-2B5F6F60-4967-4A5F-88A6-9B537A542FE7Q40715781-661CE0FE-DDB5-4F01-AC36-C7FA39D7E26AQ42040131-87A32A77-56FD-4683-B48F-ED5588A0F3D7Q51567300-D0438890-5941-46B1-AA6D-AE02DD658DA6
P2860
The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The polysaccharide inulin is c ...... th varying biological actions.
@ast
The polysaccharide inulin is c ...... th varying biological actions.
@en
type
label
The polysaccharide inulin is c ...... th varying biological actions.
@ast
The polysaccharide inulin is c ...... th varying biological actions.
@en
prefLabel
The polysaccharide inulin is c ...... th varying biological actions.
@ast
The polysaccharide inulin is c ...... th varying biological actions.
@en
P2860
P356
P1433
P1476
The polysaccharide inulin is c ...... th varying biological actions.
@en
P2093
Milena Ginic-Markovic
Peter D Cooper
P2860
P304
P356
10.1093/GLYCOB/CWT053
P577
2013-07-12T00:00:00Z